Rencord Life Sciences Private Limited, a active private limited company, was established on 10 March 2011 in Kanpur, Uttar Pradesh, India. Engaging in preventive health services within the manufacturing sector, it holds CIN: U85191UP2011PTC043919. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.22 M.
Formerly known as Concord Medipharma Private Limited. It upholds a compliant status. Employing 33 professional, Its leadership includes Satyajit Singh (Director), Tushar Gupta (Director), Abhishek Kumar Trivedi (Director). Past directors included Anurag Tripathi, Satyajit Singh, Tushar Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No- 256, Express Road, Kanpur Nagar Kanpur, Kanpur, Uttar Pradesh, 208001.
U85191UP2011PTC043919
043919
10 March 2011
₹1.00 M
₹0.22 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Rencord Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyajit Singh | Director | 11 Aug 2013 | Current |
| Tushar Gupta | Director | 21 Jan 2013 | Current |
| Abhishek Kumar Trivedi | Director | 21 Jan 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2015 | Past |
| Pramod Abcsdd | Director | 10 Apr 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 09 Dec 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rencord Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 49.57% increase. The company also saw a substantial improvement in profitability, with a 87.38% increase in profit. The company's net worth Soared by an impressive increase of 70.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Rencord Life Sciences had a promoter holding of 90.91% and a public holding of 9.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rencord Life Sciences has a workforce of 33 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rencord Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rencord Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rencord Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rencord Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Satyajit Singh was appointed as a Director was appointed as a Director on 11 Aug 2013 & has been associated with this company since 12 years 3 months . was documented.
Tushar Gupta was appointed as a Director was appointed as a Director on 21 Jan 2013 & has been associated with this company since 12 years 10 months . was recorded as a recent event.
Abhishek Kumar Trivedi was appointed as a Director was appointed as a Director on 21 Jan 2013 & has been associated with this company since 12 years 10 months . was recorded as a recent event.
The activity Rencord Life Sciences Private Limited was registered on 10 Mar 2011 with Roc Kanpur & aged 14 years 8 months as per MCA records. was completed.
The CIN of Rencord Life Sciences Private Limited is U85191UP2011PTC043919.
Rencord Life Sciences Private Limited is headquartered at Plot No- 256, Express Road, Kanpur Nagar Kanpur, Kanpur, Uttar Pradesh, 208001.
Rencord Life Sciences Private Limited was incorporated on 10 March 2011.
The current directors of Rencord Life Sciences Private Limited are
The primary industry of Rencord Life Sciences Private Limited is Manufacturing.
Rencord Life Sciences Private Limited is unlisted.
The authorized capital of Rencord Life Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.22 M.
The compliance status of Rencord Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX